Cargando…

EGF +61A/G polymorphism contributes to increased gastric cancer risk: evidence from a meta-analysis

BACKGROUND: Epidermal growth factor (EGF) plays a pivotal role in cell proliferation, differentiation, and tumorigenesis of epithelial tissues. Variation of the EGF +61A/G (rs4444903) can lead to an alteration in EGF production and/or activity, which may result in individual susceptibility to gastri...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Qiliu, Li, Shan, Qin, Xue, Lao, Xianjun, Chen, Zhiping, Zhang, Xiaolian, Chen, Junqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344773/
https://www.ncbi.nlm.nih.gov/pubmed/25729328
http://dx.doi.org/10.1186/s12935-014-0134-4
_version_ 1782359485178707968
author Peng, Qiliu
Li, Shan
Qin, Xue
Lao, Xianjun
Chen, Zhiping
Zhang, Xiaolian
Chen, Junqiang
author_facet Peng, Qiliu
Li, Shan
Qin, Xue
Lao, Xianjun
Chen, Zhiping
Zhang, Xiaolian
Chen, Junqiang
author_sort Peng, Qiliu
collection PubMed
description BACKGROUND: Epidermal growth factor (EGF) plays a pivotal role in cell proliferation, differentiation, and tumorigenesis of epithelial tissues. Variation of the EGF +61A/G (rs4444903) can lead to an alteration in EGF production and/or activity, which may result in individual susceptibility to gastric cancer. Studies investigating the association between EGF +61A/G polymorphism and gastric cancer risk produced inconsistent results. The aim of this study was to quantitatively summarize the evidence for such an association. METHODS: Eligible studies on the association between EGF +61A/G polymorphism and gastric cancer risk were identified by search of electronic databases including PubMed, EMBASE, Cochrane Library, and Chinese Biomedical Literature database (CBM). Data were extracted by two independent authors and pooled odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of the association. Metaregression and subgroup analyses were performed to identify the source of heterogeneity. RESULTS: Finally, six case–control studies with 1547 gastric cancer cases and 2762 controls were eventually identified. Overall, significant increased gastric cancer risk was found when all studies were pooled in the meta-analysis (GG vs. AA: OR = 1.438, 95% CI 1.021–2.025, P = 0.038; GG + AG vs. AA: OR = 1.256, 95% CI 1.025–1.539, P = 0.028; GG vs. AG + AA: OR = 1.265, 95% CI 1.002–1.596, P = 0.048). In subgroup analysis by ethnicity, source of control, study quality, and HWE in controls, significant increased gastric cancer risk was observed in Asians, population-based studies, high quality studies, and studies consistent with HWE. In subgroup analysis according to tumor location, and histological type, significant association was observed in all subgroups. CONCLUSIONS: This meta-analysis suggested that the EGF +61A/G polymorphism contributes to increased gastric cancer risk, especially in Asian populations. Further well-designed studies based on large sample size in diverse populations are needed to confirm this association.
format Online
Article
Text
id pubmed-4344773
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43447732015-03-01 EGF +61A/G polymorphism contributes to increased gastric cancer risk: evidence from a meta-analysis Peng, Qiliu Li, Shan Qin, Xue Lao, Xianjun Chen, Zhiping Zhang, Xiaolian Chen, Junqiang Cancer Cell Int Primary Research BACKGROUND: Epidermal growth factor (EGF) plays a pivotal role in cell proliferation, differentiation, and tumorigenesis of epithelial tissues. Variation of the EGF +61A/G (rs4444903) can lead to an alteration in EGF production and/or activity, which may result in individual susceptibility to gastric cancer. Studies investigating the association between EGF +61A/G polymorphism and gastric cancer risk produced inconsistent results. The aim of this study was to quantitatively summarize the evidence for such an association. METHODS: Eligible studies on the association between EGF +61A/G polymorphism and gastric cancer risk were identified by search of electronic databases including PubMed, EMBASE, Cochrane Library, and Chinese Biomedical Literature database (CBM). Data were extracted by two independent authors and pooled odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of the association. Metaregression and subgroup analyses were performed to identify the source of heterogeneity. RESULTS: Finally, six case–control studies with 1547 gastric cancer cases and 2762 controls were eventually identified. Overall, significant increased gastric cancer risk was found when all studies were pooled in the meta-analysis (GG vs. AA: OR = 1.438, 95% CI 1.021–2.025, P = 0.038; GG + AG vs. AA: OR = 1.256, 95% CI 1.025–1.539, P = 0.028; GG vs. AG + AA: OR = 1.265, 95% CI 1.002–1.596, P = 0.048). In subgroup analysis by ethnicity, source of control, study quality, and HWE in controls, significant increased gastric cancer risk was observed in Asians, population-based studies, high quality studies, and studies consistent with HWE. In subgroup analysis according to tumor location, and histological type, significant association was observed in all subgroups. CONCLUSIONS: This meta-analysis suggested that the EGF +61A/G polymorphism contributes to increased gastric cancer risk, especially in Asian populations. Further well-designed studies based on large sample size in diverse populations are needed to confirm this association. BioMed Central 2014-12-12 /pmc/articles/PMC4344773/ /pubmed/25729328 http://dx.doi.org/10.1186/s12935-014-0134-4 Text en © Peng et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Primary Research
Peng, Qiliu
Li, Shan
Qin, Xue
Lao, Xianjun
Chen, Zhiping
Zhang, Xiaolian
Chen, Junqiang
EGF +61A/G polymorphism contributes to increased gastric cancer risk: evidence from a meta-analysis
title EGF +61A/G polymorphism contributes to increased gastric cancer risk: evidence from a meta-analysis
title_full EGF +61A/G polymorphism contributes to increased gastric cancer risk: evidence from a meta-analysis
title_fullStr EGF +61A/G polymorphism contributes to increased gastric cancer risk: evidence from a meta-analysis
title_full_unstemmed EGF +61A/G polymorphism contributes to increased gastric cancer risk: evidence from a meta-analysis
title_short EGF +61A/G polymorphism contributes to increased gastric cancer risk: evidence from a meta-analysis
title_sort egf +61a/g polymorphism contributes to increased gastric cancer risk: evidence from a meta-analysis
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344773/
https://www.ncbi.nlm.nih.gov/pubmed/25729328
http://dx.doi.org/10.1186/s12935-014-0134-4
work_keys_str_mv AT pengqiliu egf61agpolymorphismcontributestoincreasedgastriccancerriskevidencefromametaanalysis
AT lishan egf61agpolymorphismcontributestoincreasedgastriccancerriskevidencefromametaanalysis
AT qinxue egf61agpolymorphismcontributestoincreasedgastriccancerriskevidencefromametaanalysis
AT laoxianjun egf61agpolymorphismcontributestoincreasedgastriccancerriskevidencefromametaanalysis
AT chenzhiping egf61agpolymorphismcontributestoincreasedgastriccancerriskevidencefromametaanalysis
AT zhangxiaolian egf61agpolymorphismcontributestoincreasedgastriccancerriskevidencefromametaanalysis
AT chenjunqiang egf61agpolymorphismcontributestoincreasedgastriccancerriskevidencefromametaanalysis